Silchester International Investors Llp Raised Korea Electric Pwr (KEP) Position; Bell State Bank & Trust Lowered Bristol Myers Squibb Co (BMY) Stake

June 26, 2017 - By Vivian Park

Bell State Bank & Trust decreased Bristol Myers Squibb Co (BMY) stake by 25.42% reported in 2016Q4 SEC filing. Bell State Bank & Trust sold 23,675 shares as Bristol Myers Squibb Co (BMY)’s stock declined 1.04%. The Bell State Bank & Trust holds 69,445 shares with $4.06 million value, down from 93,120 last quarter. Bristol Myers Squibb Co now has $92.40B valuation. The stock rose 0.23% or $0.13 reaching $56.77. About 2.22 million shares traded. Bristol-Myers Squibb Co (NYSE:BMY) has declined 23.19% since June 26, 2016 and is downtrending. It has underperformed by 39.89% the S&P500.

Silchester International Investors Llp increased Korea Electric Pwr (KEP) stake by 22.24% reported in 2016Q4 SEC filing. Silchester International Investors Llp acquired 4.46 million shares as Korea Electric Pwr (KEP)’s stock rose 7.41%. The Silchester International Investors Llp holds 24.50M shares with $452.79 million value, up from 20.04 million last quarter. Korea Electric Pwr now has $24.07B valuation. The stock rose 0.21% or $0.04 reaching $18.66 per share. About 97,772 shares traded. Korea Electric Power Corporation (ADR) (NYSE:KEP) has declined 25.10% since June 26, 2016 and is downtrending. It has underperformed by 41.80% the S&P500.

Investors sentiment decreased to 0.97 in Q4 2016. Its down 0.16, from 1.13 in 2016Q3. It turned negative, as 86 investors sold BMY shares while 529 reduced holdings. 126 funds opened positions while 468 raised stakes. 1.14 billion shares or 1.92% more from 1.12 billion shares in 2016Q3 were reported. 5,238 are held by Berkshire Asset Ltd Pa. Nippon Life Global Investors Americas holds 306,090 shares or 1.65% of its portfolio. Rainier Invest Mgmt Ltd Company, a Washington-based fund reported 48,350 shares. Moreover, Leisure Cap Management has 0.2% invested in Bristol-Myers Squibb Co (NYSE:BMY) for 3,713 shares. Congress Asset Mgmt Ma invested 0.66% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). 35,299 were reported by Campbell Newman Asset Mgmt. Chesley Taft Assoc Limited Liability reported 0.11% in Bristol-Myers Squibb Co (NYSE:BMY). Jacobs Levy Equity Mgmt invested 0.53% of its portfolio in Bristol-Myers Squibb Co (NYSE:BMY). Tru Investment Advsr invested in 18,075 shares. The New York-based Joel Isaacson Limited Liability Corporation has invested 0.15% in Bristol-Myers Squibb Co (NYSE:BMY). Balasa Dinverno & Foltz Ltd Company reported 11,622 shares. Rand Wealth Limited holds 21,337 shares. Regentatlantic Cap Limited Liability Company invested in 13,921 shares. New York Life Company has invested 0.05% in Bristol-Myers Squibb Co (NYSE:BMY). Argent Capital Lc owns 7,958 shares for 0.02% of their portfolio.

Among 17 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 7 have Buy rating, 3 Sell and 7 Hold. Therefore 41% are positive. Bristol-Myers Squibb Company had 37 analyst reports since July 28, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, September 29 by UBS. Jefferies maintained Bristol-Myers Squibb Co (NYSE:BMY) on Tuesday, March 15 with “Hold” rating. The stock of Bristol-Myers Squibb Co (NYSE:BMY) earned “Buy” rating by Guggenheim on Wednesday, December 2. The company was maintained on Monday, May 9 by Credit Suisse. As per Thursday, July 14, the company rating was maintained by Jefferies. The company was upgraded on Monday, December 19 by Jefferies. The stock of Bristol-Myers Squibb Co (NYSE:BMY) has “Equal-Weight” rating given on Friday, September 9 by Barclays Capital. The company was initiated on Wednesday, April 6 by Societe Generale. The rating was maintained by BMO Capital Markets with “Market Perform” on Wednesday, April 5. Piper Jaffray upgraded Bristol-Myers Squibb Co (NYSE:BMY) on Monday, August 24 to “Underweight” rating.

Since February 27, 2017, it had 1 buying transaction, and 6 sales for $9.91 million activity. Schmukler Louis S sold 15,000 shares worth $851,220. Another trade for 34,000 shares valued at $1.91M was sold by ANDREOTTI LAMBERTO. Samuels Theodore R. II had bought 12,000 shares worth $681,240 on Monday, February 27. Another trade for 8,096 shares valued at $463,779 was sold by Caldarella Joseph C. $5.27 million worth of stock was sold by LEUNG SANDRA on Friday, March 3.

Analysts await Bristol-Myers Squibb Co (NYSE:BMY) to report earnings on July, 27. They expect $0.73 earnings per share, up 5.80% or $0.04 from last year’s $0.69 per share. BMY’s profit will be $1.19B for 19.44 P/E if the $0.73 EPS becomes a reality. After $0.84 actual earnings per share reported by Bristol-Myers Squibb Co for the previous quarter, Wall Street now forecasts -13.10% negative EPS growth.